Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic non-GAAP R&D Expense (% of Revenue) (%)
Annual figures from Medtronic's filings and investor materials
Latest, FY2026
7.9%
Period ended Apr 30, 2026
Change on a year earlier
-0.2 pts
8.1% in FY2025
History
8 years
Since FY2019
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP R&D Expense (% of Revenue) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 7.9% | -0.2 pts | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 8.1% | -0.2 pts | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2024 | Apr 30, 2024 | 8.3% | -0.1 pts | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2023 | Apr 30, 2023 | 8.4% | -0.1 pts | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | 8.5% | +0.3 pts | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2021 | Apr 30, 2021 | 8.2% | +0.2 pts | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2020 | Apr 30, 2020 | 8.0% | +0.4 pts | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2019 | Apr 30, 2019 | 7.6% | – | Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗ |
Cite this data
StockData. (2026). Medtronic Non-GAAP R&D Expense (% of Revenue) (%), annual FY2019–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ng-rd-pct
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.